GT Medical Technologies, Inc.

GT Medical Technologies, Inc. is a medical device company based in Tempe, Arizona. The company is dedicated to improving outcomes for patients with operable brain tumors through innovative radiation therapy solutions. Founded by specialists in brain tumors and medical device experts, GT Medical focuses on addressing the needs in treating both recurrent and newly diagnosed intracranial neoplasms. The flagship product, GammaTile® Therapy, is an FDA-cleared, bioabsorbable collagen implant embedded with radiation seeds. This Surgically Targeted Radiation Therapy (STaRT) is placed directly into the surgical cavity during tumor resection, delivering immediate and localized radiation to residual tumor cells. This approach minimizes the risk of regrowth while protecting healthy brain tissue. GT Medical is actively advancing GammaTile through clinical trials, including studies for newly diagnosed brain metastases and glioblastoma. GT Medical collaborates with neurosurgeons, radiation oncologists, and healthcare providers to implement GammaTile therapy, emphasizing patient-focused care and compliance. The company is expanding its operations across the US, supported by recent financing to enhance its footprint and fund ongoing studies.